Log in
NASDAQ:SBRA

Sabra Health Care REIT Stock Forecast, Price & News

$13.86
+0.06 (+0.43 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$13.52
Now: $13.87
$13.90
50-Day Range
$13.57
MA: $15.09
$16.01
52-Week Range
$5.55
Now: $13.87
$24.95
Volume1.38 million shs
Average Volume2.20 million shs
Market Capitalization$2.85 billion
P/E Ratio22.01
Dividend Yield8.70%
Beta1.29
As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (“Senior Housing - Leased”), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing - Managed communities. As of December 31, 2018, Sabra's real estate properties held for investment included 47,648 beds/units and its unconsolidated joint venture included 7,652 beds/units, spread across the United States and Canada.
Read More
Sabra Health Care REIT logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.07 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
Current SymbolNASDAQ:SBRA
CUSIP78573L10
Phone888-393-8248

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$661.74 million
Cash Flow$1.13 per share
Book Value$17.24 per share

Profitability

Net Income$69 million

Miscellaneous

Employees31
Market Cap$2.85 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$13.86
+0.06 (+0.43 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SBRA News and Ratings via Email

Sign-up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sabra Health Care REIT (NASDAQ:SBRA) Frequently Asked Questions

How has Sabra Health Care REIT's stock been impacted by Coronavirus (COVID-19)?

Sabra Health Care REIT's stock was trading at $13.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SBRA stock has increased by 3.9% and is now trading at $13.8650.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Sabra Health Care REIT?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Sabra Health Care REIT
.

When is Sabra Health Care REIT's next earnings date?

Sabra Health Care REIT is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Sabra Health Care REIT
.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT Inc (NASDAQ:SBRA) released its quarterly earnings results on Wednesday, August, 5th. The real estate investment trust reported $0.14 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.40 by $0.26. Sabra Health Care REIT had a net margin of 21.00% and a return on equity of 3.78%.
View Sabra Health Care REIT's earnings history
.

How often does Sabra Health Care REIT pay dividends? What is the dividend yield for Sabra Health Care REIT?

Sabra Health Care REIT declared a quarterly dividend on Wednesday, August 5th. Shareholders of record on Monday, August 17th will be given a dividend of $0.30 per share on Monday, August 31st. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.65%. The ex-dividend date is Friday, August 14th.
View Sabra Health Care REIT's dividend history
.

What price target have analysts set for SBRA?

10 analysts have issued 1-year target prices for Sabra Health Care REIT's shares. Their forecasts range from $14.00 to $25.00. On average, they expect Sabra Health Care REIT's share price to reach $17.56 in the next twelve months. This suggests a possible upside of 26.6% from the stock's current price.
View analysts' price targets for Sabra Health Care REIT
.

Who are some of Sabra Health Care REIT's key competitors?

What other stocks do shareholders of Sabra Health Care REIT own?

Who are Sabra Health Care REIT's key executives?

Sabra Health Care REIT's management team includes the following people:
  • Mr. Richard K. Matros, Chairman, Pres & CEO (Age 65)
  • Mr. Harold W. Andrews Jr., Exec. VP, CFO & Sec. (Age 55)
  • Ms. Talya Nevo-Hacohen, Exec. VP, Chief Investment Officer & Treasurer (Age 59)
  • Mr. Brent P. Chappell, Exec. VP & Portfolio Mang. (Age 54)
  • Mr. Michael Costa, Exec. VP of Fin.

What is Sabra Health Care REIT's stock symbol?

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

Who are Sabra Health Care REIT's major shareholders?

Sabra Health Care REIT's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (16.08%), Principal Financial Group Inc. (4.76%), Principal Financial Group Inc. (4.75%), Bank of New York Mellon Corp (3.62%), APG Asset Management US Inc. (2.18%) and LSV Asset Management (1.75%). Company insiders that own Sabra Health Care REIT stock include Michael J Foster, Raymond J Lewis, Richard K Matros and Robert A Ettl.
View institutional ownership trends for Sabra Health Care REIT
.

Which major investors are selling Sabra Health Care REIT stock?

SBRA stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, APG Asset Management N.V., UBS Group AG, MERIAN GLOBAL INVESTORS UK Ltd, Prudential Financial Inc., Goldman Sachs Group Inc., Two Sigma Advisers LP, and LSV Asset Management. Company insiders that have sold Sabra Health Care REIT company stock in the last year include Richard K Matros, and Robert A Ettl.
View insider buying and selling activity for Sabra Health Care REIT
.

Which major investors are buying Sabra Health Care REIT stock?

SBRA stock was purchased by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., APG Asset Management US Inc., Russell Investments Group Ltd., Lasalle Investment Management Securities LLC, Sumitomo Mitsui Trust Holdings Inc., Nuveen Asset Management LLC, and Vanguard Group Inc..
View insider buying and selling activity for Sabra Health Care REIT
.

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sabra Health Care REIT's stock price today?

One share of SBRA stock can currently be purchased for approximately $13.87.

How big of a company is Sabra Health Care REIT?

Sabra Health Care REIT has a market capitalization of $2.85 billion and generates $661.74 million in revenue each year. The real estate investment trust earns $69 million in net income (profit) each year or $1.86 on an earnings per share basis. Sabra Health Care REIT employs 31 workers across the globe.

What is Sabra Health Care REIT's official website?

The official website for Sabra Health Care REIT is www.sabrahealth.com.

How can I contact Sabra Health Care REIT?

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The real estate investment trust can be reached via phone at 888-393-8248 or via email at [email protected]

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.